Forskellen i biotilgængeligheden var mindre tydelig ved steady- state indgivelse til nyretransplanterede patienter, og terapeutisk ækvivalens er påvist i en randomiseret undersøgelse af 477 patienter.
The difference in bioavailability was less marked upon steady-state administration to renal transplant recipients, and therapeutic equivalence has been demonstrated in randomised study of 477 patients.